| 3D | Three dimensional |
| 5-FU | 5-Fluorouracil |
| CRC | Colorectal cancer |
| CT | Computed tomography |
| DCFH-DA | 2’,7’-Dichlorofluorescein diacetate |
| DMEM | Dulbecco’s modified Eagle’s medium |
| FBS | Fetal bovine serum |
| FDG | 18F-fluoro-2-deoxy-d-glucose |
| GBM | Glioblastoma multiforme |
| HEPES | 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid |
| IR | Infrared radiation |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NSCLC | Non-small cell lung carcinoma |
| PBS | Phosphate buffered saline |
| PE | Plating efficiency |
| PET | Positron emission tomography |
| PI | Propidium iodide |
| ROI | Region of interest |
| ROS | Reactive oxygen species |
| SD | Standard deviation |
| SUV | Standard uptake value |
| TTFields | Tumor-treating fields |
| TUNEL | Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling |
| RT | Radiotherapy |
| SF | Surviving fraction |